Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by d_trumpon Apr 21, 2016 7:25pm
313 Views
Post# 24796693

RE:RE:RE:RE:RE:65 USD +

RE:RE:RE:RE:RE:65 USD +I sure hope all you guys are right about $65USD, but to me that is a steep price, especially for private equity.  Forget about the secondary offer price from last summer, that is irrelevant.  $65 US represents a FORWARD Ebitda multiple of 10.5 - thats the only way private equity would look at it.

10.5 x 625M USD midpoint 2016 midpoint guidance = $6.56B less 3.3B debt = 3.26B
divide by 51M shares = $64
 
<< Previous
Bullboard Posts
Next >>